跳至主要内容
临床试验/NCT05774054
NCT05774054已完成不适用

The Impact of Early Norepinephrine Administration on Outcomes of Patients With Sepsis-induced Hypotension

Tanta University1 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2021年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
64
试验地点
1
主要终点
the required duration to achieve the target MAP

研究概览

简要总结

Septic shock is defined as sepsis with persistent hypotension requiring vasopressors to maintain mean arterial pressure (MAP)≥ 65 mmHg and a serum lactate level of > 2 mmol/L (18 mg/dL) despite sufficient volume resuscitation

. Hypovolemia (both relative and absolute) and reduced vascular tone have a role in determining the severity of hypotension in septic shock

详细描述

Septic shock is defined as sepsis with persistent hypotension requiring vasopressors to maintain mean arterial pressure (MAP)≥ 65 mmHg and a serum lactate level of > 2 mmol/L (18 mg/dL) despite sufficient volume resuscitation . Hypovolemia (both relative and absolute) and reduced vascular tone have a role in determining the severity of hypotension in septic shock

. When mean arterial pressure (MAP) falls below a specific critical level organ blood flow is physiologically dependent on perfusion pressure. Fluid resuscitation and vasopressors have an influence on hypovolemia and the vascular tone in the early phase, as fluid resuscitation aims to correct hypovolemia and vasopressors-norepinephrine (NE)- as a first-line drug aiming to restore vascular tone to assure organ perfusion

. Norepinephrine is both an alpha1- and beta1-agonist so it is able to increase vascular tone and contractility

. Nevertheless, a large amount of fluids will increase the risk of fluid overload, which is a common complication during septic shock resuscitation

  • After the early phase, only fifty percent of patients respond to fluid administration, meaning that fluid treatment cannot boost cardiac output (CO) The current data indicate that the time from the onset of septic shock to the initiation of norepinephrine administration is a significant survival predictor; however, a suggestion for the optimal time to provide norepinephrine support was not explicitly expressed

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients aged from18 to 65 years old
  • had the diagnostic criteria for sepsis as the presence of infection
  • systemic manifestations of infection and signs of Hypoperfusion

排除标准

  • Acute cerebral vascular event
  • Active cardiac conditions
  • Valvular heart diseases
  • Hypotension suspected to be due to another cause and comorbidities
  • Status asthmatics
  • Active hemorrhage
  • Pregnancy
  • Burn injury
  • Requirement for immediate surgery
  • Advanced-stage cancer
  • Refusal to participate in the study

研究组 & 干预措施

A

Active Comparator

patients received (30ml /kg) ringer's lactate solution after first presentation then norepinephrine was added when persistent mean arterial pressure (MAP)> 65 mmHg despite adequate fluid resuscitation

干预措施: Crystalloid (Drug)

B

Active Comparator

patients received ( 30ml /kg) ringer's lactate solution after first presentation combined with norepinephrine infusion (0.05 mic/kg/min)

干预措施: noradrenaline (Drug)

结局指标

主要结局

the required duration to achieve the target MAP

时间窗: 24 hours since the diagnosis of sepsis

time to achieve target mean arterial pressure over or equal to 65 mmHg once the diagnosis of sepsis is confirmed, is the target to stop fluid management.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

tarek abdel hay mostafa

principle investigator

Tanta University

研究点 (1)

Loading locations...

相似试验

The Impact of Early Norepinephrine Administration on... | 临床试验